Custom peptides & Antibodie Primary Antibodie Secondary Antibodies Isotype and Serum Controls ELISA Kits ELISA Kits and reagents for Infectious Disease and Vaccine research ELISA Kits and reagents for Therapeutic mAbs, biosimilars, and proteins Infectious animal disease reagents for vaccine research ELISA, Western, LFA, IHC/ICC, and IP reagents Peptides, Proteins, Enzymes, cDNAs, Aptamers, Adjuvants and ODNs IHC/ICC Slides and Lysates for Westerns TruStrip™ Rapid Tests and Sample Transfer Strips CORONAVIRUS New Products
ADI成立于1993年,为研究应用提供定制抗体和免疫分析。早期的主要重点是研究人员不容易获得的免疫分析试剂和试剂盒的开发。作为人类基因组计划和人类蛋白质组计划的结果,几个新的蛋白质被迅速识别。然而,目前还没有现成的试剂对这些新鉴定的蛋白质进行详细的研究。ADI能够为世界各地的研究人员提供许多新颖的试剂,使他们能够在蛋白质组学研究中取得快速进展。多年来,该公司扩大了其重点和产品开发努力,为疫苗治疗、生物药物、传染病检测等未满足的需求提供解决方案,还有其他面向消费者市场的新产品,包括肉类掺假检测和家用宠物和农场动物生育监测的快速检测。
ADI was founded in 1993 as a provider of custom antibodies and immunoassays for research applications. The primary focus during the early years was the development of immunoassay reagents and kits that were not readily available to researchers. As a result of the human genome project and the human proteome initiative, several new proteins were rapidly identified. However, there were no readily available reagents for carrying out detailed studies on these newly identified proteins. ADI was able to supply researchers worldwide with a number of novel reagents that enabled them to make rapid strides in proteomic research. Over the years, the company expanded its focus and product development efforts to providing solutions for unmet needs in vaccine therapeutics, biologic drugs, infectious disease testing, and other novel products directed to the consumer market which includes meat adulteration testing and rapid tests for fertility monitoring in household pets and farm animals.